E Alfonso Romero-Sandoval1, Ashley L Kolano2, P Abigail Alvarado-Vázquez3. 1. Department of Anesthesiology, Pain Mechanisms Laboratory, Anesthesiology, Wake Forest University School of Medicine, 1 Medical Center Boulevard, Winston-Salem, NC, 27157, USA. earomero.sandoval@gmail.com. 2. Department of Pharmaceutical and Administrative Sciences, Presbyterian College School of Pharmacy, 307 N. Broad St, Clinton, SC, 29325, USA. 3. Department of Anesthesiology, Pain Mechanisms Laboratory, Anesthesiology, Wake Forest University School of Medicine, 1 Medical Center Boulevard, Winston-Salem, NC, 27157, USA.
Abstract
PURPOSE OF REVIEW: The purpose of this study was to provide the most up-to-date scientific evidence of the potential analgesic effects, or lack thereof, of the marijuana plant (cannabis) or cannabinoids, and of safety or tolerability of their long-term use. RECENT FINDINGS: We found that inhaled (smoked or vaporized) cannabis is consistently effective in reducing chronic non-cancer pain. Oral cannabinoids seem to improve some aspects of chronic pain (sleep and general quality of life), or cancer chronic pain, but they do not seem effective in acute postoperative pain, abdominal chronic pain, or rheumatoid pain. The available literature shows that inhaled cannabis seems to be more tolerable and predictable than oral cannabinoids. Cannabis or cannabinoids are not universally effective for pain. Continued research on cannabis constituents and improving bioavailability for oral cannabinoids is needed. Other aspects of pain management in patients using cannabis require further open discussion: concomitant opioid use, medical vs. recreational cannabis, abuse potential, etc.
PURPOSE OF REVIEW: The purpose of this study was to provide the most up-to-date scientific evidence of the potential analgesic effects, or lack thereof, of the marijuana plant (cannabis) or cannabinoids, and of safety or tolerability of their long-term use. RECENT FINDINGS: We found that inhaled (smoked or vaporized) cannabis is consistently effective in reducing chronic non-cancer pain. Oral cannabinoids seem to improve some aspects of chronic pain (sleep and general quality of life), or cancerchronic pain, but they do not seem effective in acute postoperative pain, abdominal chronic pain, or rheumatoid pain. The available literature shows that inhaled cannabis seems to be more tolerable and predictable than oral cannabinoids. Cannabis or cannabinoids are not universally effective for pain. Continued research on cannabis constituents and improving bioavailability for oral cannabinoids is needed. Other aspects of pain management in patients using cannabis require further open discussion: concomitant opioid use, medical vs. recreational cannabis, abuse potential, etc.
Entities:
Keywords:
Marijuana; Medical cannabis; Medical marijuana; Medicinal cannabis; Medicinal marijuana; Recreational cannabis; Recreational marijuana
Authors: J P Zajicek; H P Sanders; D E Wright; P J Vickery; W M Ingram; S M Reilly; A J Nunn; L J Teare; P J Fox; A J Thompson Journal: J Neurol Neurosurg Psychiatry Date: 2005-12 Impact factor: 10.154
Authors: Marjan de Vries; Dagmar C M van Rijckevorsel; Kris C P Vissers; Oliver H G Wilder-Smith; Harry van Goor Journal: Clin Gastroenterol Hepatol Date: 2016-10-05 Impact factor: 11.382
Authors: Jennifer Jean-Jacques; Robert Cook; Almut G Winterstein; Amie Goodin; Joshua D Brown; Sebastian Jugl; Yan Wang Journal: Med Cannabis Cannabinoids Date: 2021-08-02
Authors: Leslie W Suen; Vanessa M McMahan; Christopher Rowe; Sumeet Bhardwaj; Kelly Knight; Margot B Kushel; Glenn-Milo Santos; Phillip Coffin Journal: J Am Board Fam Med Date: 2021 Nov-Dec Impact factor: 2.395
Authors: Han Zhang; Michael Xie; Stuart D Archibald; B Stanley Jackson; Michael K Gupta Journal: JAMA Otolaryngol Head Neck Surg Date: 2018-11-01 Impact factor: 6.223